1. Home
  2. SNY vs ESQ Comparison

SNY vs ESQ Comparison

Compare SNY & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • ESQ
  • Stock Information
  • Founded
  • SNY 1994
  • ESQ 2006
  • Country
  • SNY France
  • ESQ United States
  • Employees
  • SNY N/A
  • ESQ N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • ESQ Commercial Banks
  • Sector
  • SNY Health Care
  • ESQ Finance
  • Exchange
  • SNY Nasdaq
  • ESQ Nasdaq
  • Market Cap
  • SNY 116.5B
  • ESQ 756.3M
  • IPO Year
  • SNY N/A
  • ESQ 2017
  • Fundamental
  • Price
  • SNY $48.61
  • ESQ $96.35
  • Analyst Decision
  • SNY Buy
  • ESQ Hold
  • Analyst Count
  • SNY 2
  • ESQ 3
  • Target Price
  • SNY $62.50
  • ESQ $99.00
  • AVG Volume (30 Days)
  • SNY 2.2M
  • ESQ 171.0K
  • Earning Date
  • SNY 07-31-2025
  • ESQ 07-24-2025
  • Dividend Yield
  • SNY 3.29%
  • ESQ 0.73%
  • EPS Growth
  • SNY 39.56
  • ESQ 13.51
  • EPS
  • SNY 5.45
  • ESQ 5.27
  • Revenue
  • SNY $48,817,552,946.00
  • ESQ $124,132,000.00
  • Revenue This Year
  • SNY $3.39
  • ESQ N/A
  • Revenue Next Year
  • SNY $7.05
  • ESQ $10.72
  • P/E Ratio
  • SNY $8.92
  • ESQ $18.32
  • Revenue Growth
  • SNY N/A
  • ESQ 14.72
  • 52 Week Low
  • SNY $45.80
  • ESQ $49.16
  • 52 Week High
  • SNY $60.12
  • ESQ $101.35
  • Technical
  • Relative Strength Index (RSI)
  • SNY 46.26
  • ESQ 56.40
  • Support Level
  • SNY $47.99
  • ESQ $93.57
  • Resistance Level
  • SNY $49.43
  • ESQ $101.28
  • Average True Range (ATR)
  • SNY 0.58
  • ESQ 3.23
  • MACD
  • SNY 0.18
  • ESQ 0.16
  • Stochastic Oscillator
  • SNY 56.15
  • ESQ 58.99

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

Share on Social Networks: